https://www.selleckchem.com/pr....oducts/pf-06463922.h
7 versus 49.2mo, P0.001) in patients with BCLM ER+ (69.6 versus 54.1mo, P=0.002) and triple-negative BC (49.2 versus 17.6mo, P=0.006). Cox regression showed that LR, chemotherapy, and positive hormone receptor status (ER+, PR+, and/or HER2+) were independent predictors of improved OS. Advanced age and comorbidity score negatively impacted OS. This is the largest series thus far assessing the role of LR in patients with BCLM. LR plus chemotherapy may be associated with acceptable outcomes in selected patients with BCLM. LR should
إعجاب
علق
شارك
